Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Momentum
Price
Volume
Vol 1d %
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
RSI
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D
MACD
MACD Signal
MACD Histogram
Beta
NKTX
NKARTA INC
$1.88719,00058.72%1.831.822.042.081.9448.8875.7276.4588.7092.31-0.04-0.060.021.55
SNDX
SYNDAX PHARMACEUTICALS INC
$20.371,184,000-37.35%19.8618.9816.6715.5213.4264.8383.7683.7737.1237.821.141.120.021.05
FBRX
FORTE BIOSCIENCES INC
$21.37212,000214.07%20.0219.0515.5013.6011.1463.2872.0266.1254.9541.601.751.620.120.83
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
$7.46684,00030.78%7.066.8111.4214.2113.3942.7888.5885.8994.6495.33-0.85-1.310.451.97
OCUL
OCULAR THERAPEUTIX INC
$14.562,834,000-21.50%13.6112.7812.0012.1510.1963.3070.5479.3963.8577.350.880.560.321.50
BLTE
BELITE BIO INC
$141.32170,000-69.37%149.55136.66111.4089.4375.6958.5270.2875.4734.4553.9111.1912.21-1.020.21
GLSI
GREENWICH LIFESCIENCES INC
$10.73155,000-41.95%9.408.839.2510.3310.2366.7886.7293.1693.7797.920.390.050.351.17
ATAI
ATAI BECKLEY NV
$4.294,116,000121.89%4.244.044.854.663.2848.4877.2981.4487.5091.16-0.09-0.190.101.42
NGNE
NEUROGENE INC
$20.92145,00042.16%20.4620.7926.2322.9419.8043.4446.4137.4896.5087.58-1.45-1.710.261.46
CRNX
CRINETICS PHARMACEUTICALS INC
$50.491,114,00049.93%47.4545.5843.8238.2534.9872.2989.6985.40100.0098.701.791.380.411.20
CRSP
CRISPR THERAPEUTICS AG
$56.681,402,0003.93%56.1654.2460.6159.2650.7950.7979.2079.9189.2291.09-0.21-1.090.881.52
NVAX
NOVAVAX INC
$6.572,921,00010.39%6.736.707.657.887.4139.2047.2455.1266.0076.15-0.24-0.290.051.73
MBX
MBX BIOSCIENCES INC
$29.86429,000-47.94%30.9829.9623.0418.4014.3456.3430.7334.324.782.321.872.65-0.781.54
AVXL
ANAVEX LIFE SCIENCES CORP
$4.024,850,000210.10%4.193.846.578.208.6236.4557.0362.9882.6686.92-0.62-0.820.201.74
RNXT
RENOVORX INC
$0.96158,000-16.84%0.930.871.021.091.1151.7789.7889.3693.6097.50-0.01-0.030.020.91
PHIO
PHIO PHARMACEUTICALS CORP
$1.12184,00049.59%1.211.221.701.961.9531.6820.6021.8960.9162.18-0.14-0.160.021.21
CNTX
CONTEXT THERAPEUTICS INC
$1.04547,0002.24%1.061.091.171.010.8743.1725.8323.8234.4633.21-0.03-0.02-0.000.97
ALXO
ALX ONCOLOGY HOLDINGS INC
$1.4797,00012.79%1.411.431.541.280.9351.6977.5072.4589.3192.190.00-0.020.021.42
KLRS
KALARIS THERAPEUTICS INC
$8.87187,00021.43%6.636.485.694.695.0176.6895.6786.9696.8484.720.640.380.261.45
TRDA
ENTRADA THERAPEUTICS INC
$11.08219,0003.30%10.449.947.986.787.5873.7181.4480.3820.1817.460.850.85-0.001.06
NRSN
NEUROSENSE THERAPEUTICS LTD
$0.89152,000-54.49%1.051.071.101.191.3337.456.586.643.651.83-0.04-0.02-0.030.59
CLRB
CELLECTAR BIOSCIENCES INC
$3.6250,40026.00%3.793.423.824.406.4149.5680.4088.6777.1488.080.06-0.020.081.09
SANA
SANA BIOTECHNOLOGY INC
$5.148,092,00071.99%4.684.164.503.993.2260.6179.6470.6680.7673.990.210.080.132.11
TARA
PROTARA THERAPEUTICS INC
$5.70700,000-57.91%6.116.455.654.494.0246.1227.1526.308.987.870.090.27-0.181.14
OLMA
OLEMA PHARMACEUTICALS INC
$33.053,685,00014.55%28.7124.8215.4011.037.7383.2293.0087.7146.5530.554.914.650.271.24
CLYM
CLIMB BIO INC
$3.008,341,000610.48%1.971.901.931.981.6380.6590.9885.01100.0098.630.11-0.000.110.77
MRKR
MARKER THERAPEUTICS INC
$1.47253,00024.02%1.361.221.081.091.2267.0291.0692.5860.6670.720.120.100.031.08
CVKD
CADRENAL THERAPEUTICS INC
$11.00105,000-42.31%10.0410.3612.0512.2913.7251.0275.9266.3298.2790.91-0.40-0.650.250.74
VSTM
VERASTEM INC
$9.611,608,00032.02%10.069.859.138.727.4349.7426.6941.553.886.200.250.35-0.101.56
GHRS
GH RESEARCH PLC
$13.04252,000-21.50%14.2914.3213.8513.6012.7040.349.4020.740.004.980.010.18-0.170.99
OVID
OVID THERAPEUTICS INC
$1.64886,000-37.47%1.631.531.521.270.8256.7164.4764.1936.1343.970.060.050.010.92
QURE
UNIQURE NV
$19.511,851,000-40.17%22.3425.3941.5131.1422.3424.431.372.700.002.30-5.14-5.240.101.39
AURA
AURA BIOSCIENCES INC
$6.54157,000-4.27%6.376.055.956.226.2462.1389.5686.5572.9471.060.190.140.061.09
IMTX
IMMATICS NV
$10.04238,000-62.75%10.3010.3310.138.246.6549.0111.1514.151.893.620.090.19-0.090.98
ENVB
ENVERIC BIOSCIENCES INC
$5.43294,000-81.83%6.356.026.879.4913.0945.7623.9535.1639.1046.18-0.05-0.170.121.62
ANNX
ANNEXON INC
$4.975,563,00063.96%4.624.283.573.022.6171.3482.8485.7775.6674.900.440.390.051.10
NERV
MINERVA NEUROSCIENCES INC
$3.8837,300-35.69%3.763.923.702.912.2951.1167.4762.3573.9468.240.040.04-0.000.50
APGE
APOGEE THERAPEUTICS INC
$77.081,309,00043.37%74.5470.7160.6249.1643.7073.8291.3390.0845.5941.524.994.950.041.30
RYTM
RHYTHM PHARMACEUTICALS INC
$113.561,743,000-49.04%106.32105.06105.14100.8781.7459.4565.4253.5572.3850.381.670.611.061.19
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$3.601,615,00029.20%3.613.603.372.962.6253.5857.4864.5452.1356.820.110.11-0.011.09
OABI
OMNIAB INC
$2.15649,000-29.91%1.951.831.691.731.8772.7289.9290.5398.4099.470.130.090.030.67
ANVS
ANNOVIS BIO INC
$4.131,044,000-29.79%4.374.122.882.672.3556.4326.0136.724.783.510.410.53-0.111.49
TVRD
TVARDI THERAPEUTICS INC
$4.4184,0002.44%4.204.098.9819.5820.7433.4577.5079.4796.4598.53-1.09-1.640.550.92
RVMD
REVOLUTION MEDICINES INC
$78.922,240,00010.67%78.0175.2163.0851.4544.9073.7373.4173.716.678.624.675.15-0.481.33
PHVS
PHARVARIS NV
$24.16367,00057.51%25.4825.3923.7523.1719.9947.6611.8911.083.612.660.220.61-0.390.51
MRNA
MODERNA INC
$29.4612,135,00048.57%27.0925.7826.1126.3627.5465.8394.6296.7898.3199.440.970.380.591.24
NKTR
NEKTAR THERAPEUTICS
$54.70706,000-22.76%56.7358.1258.4147.6530.6545.7718.8125.8618.0822.56-0.71-0.04-0.671.73
ADTX
ADITXT INC
$2.24193,000-31.32%2.763.1521.1068.20241.0521.2410.3923.5581.9788.98-5.06-6.831.760.60
CHRS
COHERUS ONCOLOGY INC
$1.35872,000-22.97%1.281.251.471.341.1151.4181.9578.4189.9994.11-0.02-0.050.031.57
IPSC
CENTURY THERAPEUTICS INC
$0.56502,000-51.82%0.550.530.550.540.5552.9177.2985.5481.5193.840.010.000.011.29
ATON
ALPHATON CAPITAL CORP
$1.32152,000-75.64%1.592.124.165.506.1222.753.986.8421.7733.23-0.77-0.820.051.16
SRZN
SURROZEN INC
$24.59105,000-23.36%20.1017.1214.8613.0511.3185.4293.6592.8298.9499.292.701.780.920.59
NUVL
NUVALENT INC
$104.80530,000-9.09%106.42106.5998.1488.2881.4852.6522.2427.106.538.482.353.21-0.861.49
SRPT
SAREPTA THERAPEUTICS INC
$21.532,009,000-57.94%21.6620.0820.9719.5234.1554.6280.6784.4166.6677.230.630.380.250.96
CBIO
CRESCENT BIOPHARMA INC
$14.09104,000-14.05%13.7913.7212.8812.9416.9854.3057.8451.3645.6241.060.360.300.051.18
BEAM
BEAM THERAPEUTICS INC
$27.361,563,00011.96%26.6024.7125.1222.5120.9959.2678.4677.1566.3769.721.020.660.362.08
OKUR
ONKURE THERAPEUTICS INC
$3.0749,000-62.60%3.032.953.022.762.9251.4072.8880.9173.4585.650.060.010.050.76
ACLX
ARCELLX INC
$71.86714,000-37.09%71.1577.2683.1578.3771.5940.2223.0822.7562.3951.21-3.77-3.63-0.140.99
AIXC
AIXCRYPTO HOLDINGS INC
$2.5152,300-67.72%2.482.603.122.863.1645.4248.9438.1092.4183.08-0.14-0.170.030.69
CRDF
CARDIFF ONCOLOGY INC
$2.39740,000-44.28%2.272.192.232.282.8357.8780.5286.5190.8995.980.060.020.041.51
CTMX
CYTOMX THERAPEUTICS INC
$4.191,717,00023.35%4.003.953.732.982.2658.3658.9649.0038.3221.630.100.11-0.021.33
NMRA
NEUMORA THERAPEUTICS INC
$2.09618,00029.56%2.192.302.302.011.4940.689.847.335.765.36-0.08-0.05-0.041.40
VERU
VERU INC
$2.4297,00025.97%2.502.453.113.464.5039.6165.5677.9172.1084.91-0.12-0.180.061.17
ABEO
ABEONA THERAPEUTICS INC
$5.361,016,000-23.78%5.054.834.985.685.6659.3687.9989.1592.0296.790.130.030.110.85
IFRX
INFLARX NV
$1.05582,00013.01%1.061.141.281.211.1842.3132.4133.2632.1633.69-0.07-0.07-0.010.87
IMUX
IMMUNIC INC
$0.621,624,000-26.15%0.660.690.760.830.8936.0624.2831.1448.7563.44-0.03-0.03-0.001.18
AGIO
AGIOS PHARMACEUTICALS INC
$27.271,203,000-20.44%27.4329.6936.9937.2334.5936.7865.9263.3989.6584.42-3.00-3.240.241.23
RNAC
CARTESIAN THERAPEUTICS INC
$8.52174,000-2.25%7.397.398.219.5210.8561.6684.0971.9698.8890.44-0.04-0.260.231.52
INO
INOVIO PHARMACEUTICALS INC
$2.06742,000-17.46%2.061.972.202.141.9949.2971.7379.1783.3792.49-0.01-0.050.041.55
GBIO
GENERATION BIO CO
$5.4314,200-69.98%5.295.265.665.624.8851.5571.7172.3986.5792.02-0.04-0.100.051.92
NCEL
NEWCELX LTD
$2.91111,000-52.36%3.713.608.5815.0716.8928.6929.8358.4565.5181.78-1.19-1.590.390.41
IMNN
IMUNON INC
$4.1524,500-14.34%4.003.954.385.349.8651.8674.0272.8095.1490.76-0.07-0.140.070.92
RZLT
REZOLUTE INC
$1.8035,290,000-72.59%8.189.019.148.196.0423.0933.6150.1635.1856.48-1.00-0.19-0.810.68
CAPR
CAPRICOR THERAPEUTICS INC
$26.021,786,000-3.09%23.3114.359.638.339.5371.3363.7465.0071.0874.615.884.231.651.09
ORIC
ORIC PHARMACEUTICALS INC
$9.381,038,00036.58%10.4911.1412.2611.349.4427.503.585.580.002.81-0.65-0.47-0.181.12
DMAC
DIAMEDICA THERAPEUTICS INC
$9.39606,00028.66%8.808.217.296.615.4269.3366.8174.1369.0963.320.640.550.090.86
EYPT
EYEPOINT PHARMACEUTICALS INC
$15.99720,000-35.02%16.0614.9813.3612.6810.0058.9949.4357.6634.2952.061.060.960.101.17
BCAX
BICARA THERAPEUTICS INC
$18.482,084,000493.73%18.3717.6717.0114.3713.2056.8777.3885.7240.1150.750.770.720.051.55
DRTS
ALPHA TAU MEDICAL LTD
$5.05173,000-43.83%4.274.014.013.773.3069.9796.4187.2294.7794.540.230.080.150.41
BTAI
BIOXCEL THERAPEUTICS INC
$2.01451,000-8.15%2.061.982.122.822.3548.3557.3366.3650.9866.680.00-0.030.031.64
CADL
CANDEL THERAPEUTICS INC
$6.351,415,000-59.63%5.425.005.285.485.7072.0386.0888.3697.2299.070.270.050.221.11
ELDN
ELEDON PHARMACEUTICALS INC
$1.64892,00011.64%1.601.592.562.642.9339.0980.5976.0493.6496.41-0.26-0.330.070.77
GUTS
FRACTYL HEALTH INC
$2.242,984,00019.46%2.071.741.461.331.4478.2088.2092.3583.2292.930.270.200.060.99
BCAB
BIOATLA INC
$0.82979,00060.76%0.810.890.800.650.5250.6021.8516.7320.339.630.000.02-0.011.78
IRON
DISC MEDICINE INC
$91.85504,000-19.23%92.3191.9985.5773.1561.5355.4945.3543.8921.9622.182.102.61-0.510.91
OSRH
OSR HOLDINGS INC
$0.64178,000-58.22%0.680.640.630.651.0849.2729.7741.3418.2836.650.020.02-0.00-0.03
ZURA
ZURA BIO LTD
$4.02380,000-53.66%3.793.803.802.912.0856.8076.0260.4383.1173.030.050.030.010.28
PRQR
PROQR THERAPEUTICS NV
$2.33821,000-23.20%2.172.162.382.272.0154.0077.2072.1190.6387.86-0.02-0.060.041.03
ELAB
PMGC HOLDINGS INC
$3.8567,000-48.06%4.734.895.635.908.5226.0110.9317.650.004.57-0.37-0.27-0.101.18
DNLI
DENALI THERAPEUTICS INC
$17.981,401,000-53.28%18.7318.4316.9515.6615.0150.2118.3636.765.5119.260.480.71-0.221.59
BHVN
BIOHAVEN LTD
$11.531,354,000-60.12%10.109.7212.5913.6616.7357.1092.0190.33100.0099.31-0.26-0.730.471.62
GNPX
GENPREX INC
$2.84406,000290.38%3.123.227.328.9711.8039.1651.4654.9870.0883.64-0.93-1.210.281.26
CYTK
CYTOKINETICS INC
$63.351,583,000-9.54%63.6665.0562.3552.8244.9449.7819.1612.5113.945.740.080.88-0.801.01
SGMT
SAGIMET BIOSCIENCES INC
$6.23324,000-20.59%6.346.837.467.606.2538.4322.0918.8144.1839.27-0.39-0.35-0.042.13
TENX
TENAX THERAPEUTICS INC
$10.37230,000152.75%9.658.957.927.086.4972.8180.6480.1542.2152.230.700.620.080.44
XENE
XENON PHARMACEUTICALS INC
$44.06782,000-8.64%43.9542.9441.5838.9836.0659.1158.7260.3618.2125.950.900.93-0.030.85
QNCX
QUINCE THERAPEUTICS INC
$4.22957,000-33.54%3.813.092.301.971.6375.2689.9187.6632.4939.560.610.510.100.74
STRO
SUTRO BIOPHARMA INC
$9.83122,00041.86%8.778.789.289.038.8456.4991.1479.2595.7683.570.01-0.170.171.37
BMEA
BIOMEA FUSION INC
$1.411,205,000-44.39%1.261.171.391.621.8456.7689.1688.4890.9196.080.02-0.050.071.09
PDSB
PDS BIOTECHNOLOGY CORP
$0.97536,0007.85%0.910.840.911.031.1757.0069.8777.5781.3089.150.02-0.010.031.92

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Beone Medicines (NASDAQ:ONC)


Beone Medicines (NASDAQ:ONC) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 76.99% over the past year, overperforming other biotech stocks by 122 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 22.51% from Beone Medicines's current stock price of $319.06.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)


Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: C, Momentum: B, Sentiment: B, Safety: C, Financials: A, and AI: B.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 46, which is 23 points higher than the biotech industry average of 23.

AUPH passed 15 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 63.57% over the past year, overperforming other biotech stocks by 109 percentage points.

Aurinia Pharmaceuticals has an average 1 year price target of $17.25, an upside of 8.83% from Aurinia Pharmaceuticals's current stock price of $15.85.

Aurinia Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Aurinia Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Innoviva (NASDAQ:INVA)


Innoviva (NASDAQ:INVA) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.21% over the past year, overperforming other biotech stocks by 56 percentage points.

Innoviva has an average 1 year price target of $32.00, an upside of 55.11% from Innoviva's current stock price of $20.63.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 12.13%, which is 9 percentage points higher than the biotech industry average of 2.94%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.29%, which is -1 percentage points lower than the biotech industry average of 2.94%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.94%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.42% in the last day, and up 0.28% over the last week. Sonnet Biotherapeutics Holdings was the among the top losers in the biotechnology industry, dropping -59.35% yesterday.

Sonnet BioTherapeutics Holdings shares are trading lower after the company announced its stockholders approved a business combination with Hyperliquid Strategies and Rorschach I.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 27.15% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 100.68% in the past year. It has overperformed other stocks in the biotech industry by 146 percentage points.

3. Innoviva (NASDAQ:INVA)


Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.21% in the past year. It has overperformed other stocks in the biotech industry by 56 percentage points.

Are biotech stocks a good buy now?

59.96% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 47.99% over the next year.

3.31% of biotech stocks have a Zen Rating of A (Strong Buy), 6.42% of biotech stocks are rated B (Buy), 44.93% are rated C (Hold), 32.3% are rated D (Sell), and 13.04% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 155.66x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.